Hologic SVP Rohan Hastie Sells 6,037 Shares (HOLX)
Hologic (NASDAQ:HOLX) SVP Rohan Hastie sold 6,037 shares of the company’s stock in a transaction that occurred on Friday, May 9th. The shares were sold at an average price of $24.36, for a total value of $147,061.32. Following the transaction, the senior vice president now directly owns 1,500 shares of the company’s stock, valued at approximately $36,540. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
A number of research firms have recently commented on HOLX. Analysts at Argus raised their price target on shares of Hologic from $27.00 to $31.00 in a research note on Monday. They now have a “buy” rating on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Hologic in a research note on Thursday, May 1st. They now have a $28.00 price target on the stock. Finally, analysts at RBC Capital raised their price target on shares of Hologic from $21.00 to $22.00 in a research note on Thursday, May 1st. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $23.11.
Shares of Hologic (NASDAQ:HOLX) traded up 1.97% during mid-day trading on Monday, hitting $24.88. The stock had a trading volume of 2,387,363 shares. Hologic has a 52 week low of $18.46 and a 52 week high of $25.00. The stock has a 50-day moving average of $21.74 and a 200-day moving average of $21.8. The company’s market cap is $6.875 billion.
Hologic (NASDAQ:HOLX) last issued its quarterly earnings data on Wednesday, April 30th. The company reported $0.37 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.33 by $0.04. The company had revenue of $625.00 million for the quarter, compared to the consensus estimate of $609.35 million. On average, analysts predict that Hologic will post $1.40 earnings per share for the current fiscal year.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.